NCT06093165View on ClinicalTrials.gov

RE-irradiation of Diffuse MIdline Glioma paTients

NANot yet recruitingINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions
Diffuse Midline Glioma, H3 K27M-MutantDiffuse Intrinsic Pontine GliomaDiffuse GliomaPontine TumorsThalamic TumorBrain Tumor, Pediatric
Interventions
RADIATION

Re-irradiation

20Gy on 10 fractions

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

Radiumhospitalet, Oslo University Hospital

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT06093165 - RE-irradiation of Diffuse MIdline Glioma paTients | Biotech Hunter | Biotech Hunter